The National Biodefense Strategy highlights President Donald Trump's commitment to protect the American people, “and establishes objectives to effectively counter threats from naturally occurring, accidental, and deliberate biological events.” This strategy is intended to guide innovation and collaboration beyond the federal government. The president is targeting this strategy for action by state, local, territorial, and tribal (SLTT) entities, practitioners, scientists, educators, and industry.
This report is a meeting readout. It relays the sentiments of the many experts who participated but is not an exhaustive analysis of the recommendations and how they should be implemented. It is meant to lay the groundwork for the next steps, which key leaders and policymakers should consider. The information relayed herein is generally reflective of the opinions voiced at the meeting as well as the survey respondents, though any given statement should not necessarily be viewed as consensus.
The Tribal Mitigation Planning Handbook provides practical approaches and advice for tribal governments as they develop their hazard mitigation plans. The handbook is organized around the seven recommended steps for developing a tribal mitigation plan. It also provides considerations for how to implement the mitigation plan, advance mitigation activities, and incorporate risk reduction into other tribal plans and programs.
The National Health Security Preparedness Index tracks the nation's progress in preparing for, responding to, and recovering from the health consequences of disasters, disease outbreaks, and other large-scale emergencies. This report details the key findings from this year’s Index report.
The Centers for Disease Control and Prevention developed a reference document that contains key messages on hurricane- and flood-related health threats. The document can help local responders quickly create and adapt health communication products for affected communities. The document contains messages on various topics including food safety, carbon monoxide poisoning, waterborne diseases, and mold.
The Federal Emergency Management Agency (FEMA) New Recipients of Disaster Grants Guide is intended to provide streamlined guidance to state, territorial, and tribal governments on the essential elements of FEMA Public Assistance, Individual Assistance, and Hazard Mitigation Grant Programs and required actions to request, initiate, and receive FEMA disaster assistance grants.
The Global Health Security Strategy outlines the U.S. government’s approach to strengthen global health security, including accelerating the capabilities of targeted countries to prevent, detect, and respond to infectious disease outbreaks.
Emergency alert, warning, and notification (AWN) systems help protect lives and property by identifying information about an impending threat, communicating that information to those who need it, and facilitating the timely taking of protective actions. This report contains recommendations to help organizations enhance critical information sharing.
This document provides guidance to government stakeholders on testing to extend the expiration date of stockpiled doxycycline tablets and capsules. This extension would be beneficial for public health emergency preparedness and response purposes should an anthrax emergency occur.
The Centers for Disease Control and Prevention, U.S. Department of the Interior, and U.S. Department of Agriculture have released the first federal collaborative report listing the top zoonotic diseases of national concern for the United States, including recommendations for next steps. Zoonotic diseases are illnesses that can spread between animals and people.
The Johns Hopkins Center for Health Security conducted a project aimed to develop a state-of-the-art conceptual understanding of various vaccine platform technologies, with special attention on how they may speed development of vaccines for global catastrophic biologic risks and emerging infectious disease outbreaks. This report describes major scientific and policy issues related to platforms and how they are understood in government, academia, and industry. It also provides recommendations aimed at helping realize the potential benefits of vaccine platform technologies.